This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Stuart Kamin
Senior Vice President, Corporate Strategy and Business Development at ClaritasRx
Speaker

Profile

Stuart is a healthcare analytics specialist. As SVP of Corporate Strategy & Business Development, he manages the strategic direction and deployment of the Claritas Rx technical platform in support of launches for innovative specialty medicines. He built his expertise in specialty channel data through his previous work in lifecycle pricing and contract strategy at Genentech and in global consulting with IMS Health. Stuart holds dual MBA and MPH degrees from UC Berkeley and a BS in Psychobiology from UCLA.

Agenda Sessions

  • Manufacturer Considerations for Building a Strategic Commercialization Plan

    11:00am